177 related articles for article (PubMed ID: 15599803)
1. Nicotinic acetylcholine receptor system and neuropsychiatric disorders.
Singh A; Potter A; Newhouse P
IDrugs; 2004 Dec; 7(12):1096-103. PubMed ID: 15599803
[TBL] [Abstract][Full Text] [Related]
2. [Role of smoking and nicotine in neuropsychiatric disorders: evidence for therapeutic role of nicotinic acetylcholine receptors].
Miyata H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):149-58. PubMed ID: 18800618
[TBL] [Abstract][Full Text] [Related]
3. [Nicotine acetylcholine receptors and neuropsychiatric disorders].
Vázquez-Palacios G; Bonilla-Jaime H
Rev Neurol; 2004 Dec 16-31; 39(12):1146-60. PubMed ID: 15625635
[TBL] [Abstract][Full Text] [Related]
4. Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors.
Hogg RC; Bertrand D
Biochem Pharmacol; 2007 Feb; 73(4):459-68. PubMed ID: 16979139
[TBL] [Abstract][Full Text] [Related]
5. Nicotine and nicotinic receptor involvement in neuropsychiatric disorders.
Newhouse P; Singh A; Potter A
Curr Top Med Chem; 2004; 4(3):267-82. PubMed ID: 14754447
[TBL] [Abstract][Full Text] [Related]
6. Nicotine and brain disorders.
Mihailescu S; Drucker-Colín R
Acta Pharmacol Sin; 2000 Feb; 21(2):97-104. PubMed ID: 11263271
[TBL] [Abstract][Full Text] [Related]
7. Selective nicotinic acetylcholine receptor agonists: potential therapies for neuropsychiatric disorders with cognitive dysfunction.
Cincotta SL; Yorek MS; Moschak TM; Lewis SR; Rodefer JS
Curr Opin Investig Drugs; 2008 Jan; 9(1):47-56. PubMed ID: 18183531
[TBL] [Abstract][Full Text] [Related]
8. Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them.
Xiao Y; Fan H; Musachio JL; Wei ZL; Chellappan SK; Kozikowski AP; Kellar KJ
Mol Pharmacol; 2006 Oct; 70(4):1454-60. PubMed ID: 16857741
[TBL] [Abstract][Full Text] [Related]
9. Application of nicotine enantiomers, derivatives and analogues in therapy of neurodegenerative disorders.
Pogocki D; Ruman T; Danilczuk M; Danilczuk M; Celuch M; Wałajtys-Rode E
Eur J Pharmacol; 2007 Jun; 563(1-3):18-39. PubMed ID: 17376429
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
11. Effects of nicotinic stimulation on cognitive performance.
Newhouse PA; Potter A; Singh A
Curr Opin Pharmacol; 2004 Feb; 4(1):36-46. PubMed ID: 15018837
[TBL] [Abstract][Full Text] [Related]
12. Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research.
Dursun SM; Kutcher S
Med Hypotheses; 1999 Feb; 52(2):101-9. PubMed ID: 10340289
[TBL] [Abstract][Full Text] [Related]
13. Brain nicotinic acetylcholine receptors: native subtypes and their relevance.
Gotti C; Zoli M; Clementi F
Trends Pharmacol Sci; 2006 Sep; 27(9):482-91. PubMed ID: 16876883
[TBL] [Abstract][Full Text] [Related]
14. Nicotinic receptors, allosteric proteins and medicine.
Changeux JP; Taly A
Trends Mol Med; 2008 Mar; 14(3):93-102. PubMed ID: 18262468
[TBL] [Abstract][Full Text] [Related]
15. Central nicotinic cholinergic systems: a role in the cognitive dysfunction in attention-deficit/hyperactivity disorder?
Potter AS; Newhouse PA; Bucci DJ
Behav Brain Res; 2006 Dec; 175(2):201-11. PubMed ID: 17081628
[TBL] [Abstract][Full Text] [Related]
16. Brain nicotinic receptors as emerging targets for drug addiction: neurobiology to translational research.
Rahman S
Prog Mol Biol Transl Sci; 2011; 98():349-65. PubMed ID: 21199776
[TBL] [Abstract][Full Text] [Related]
17. Nicotinic cholinergic antagonists: a novel approach for the treatment of autism.
Lippiello PM
Med Hypotheses; 2006; 66(5):985-90. PubMed ID: 16406687
[TBL] [Abstract][Full Text] [Related]
18. Desensitized nicotinic receptors in brain.
Wang H; Sun X
Brain Res Brain Res Rev; 2005 Jun; 48(3):420-37. PubMed ID: 15914250
[TBL] [Abstract][Full Text] [Related]
19. Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor.
Hernandez CM; Terry AV
Neuroscience; 2005; 130(4):997-1012. PubMed ID: 15652996
[TBL] [Abstract][Full Text] [Related]
20. Nicotinic systems in central nervous systems disease: degenerative disorders and beyond.
Newhouse PA; Kelton M
Pharm Acta Helv; 2000 Mar; 74(2-3):91-101. PubMed ID: 10812945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
